Redcare Pharmacy NV
XETRA:RDC

Watchlist Manager
Redcare Pharmacy NV Logo
Redcare Pharmacy NV
XETRA:RDC
Watchlist
Price: 64.65 EUR -1%
Market Cap: 1.3B EUR

Wall Street
Price Targets

RDC Price Targets Summary
Redcare Pharmacy NV

Wall Street analysts forecast RDC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RDC is 147.49 EUR with a low forecast of 74.74 EUR and a high forecast of 224.7 EUR.

Lowest
Price Target
74.74 EUR
16% Upside
Average
Price Target
147.49 EUR
128% Upside
Highest
Price Target
224.7 EUR
248% Upside
Redcare Pharmacy NV Competitors:
Price Targets
4164
Al Nahdi Medical Company SCJSC
2% Upside
9989
Sundrug Co Ltd
22% Upside
CRRX
CareRx Corp
30% Upside
MEDPLUS
MedPlus Health Services Ltd
36% Upside
9627
AIN Holdings Inc
15% Upside
PGMN3
Empreendimentos Pague Menos SA
17% Downside
3088
MatsukiyoCocokara & Co
22% Upside
9267
Genky DrugStores Co Ltd
9% Upside

Revenue
Forecast

Revenue Estimate
Redcare Pharmacy NV

For the last 8 years the compound annual growth rate for Redcare Pharmacy NV's revenue is 38%. The projected CAGR for the next 4 years is 19%.

38%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Redcare Pharmacy NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Redcare Pharmacy NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RDC's stock price target?
Price Target
147.49 EUR

According to Wall Street analysts, the average 1-year price target for RDC is 147.49 EUR with a low forecast of 74.74 EUR and a high forecast of 224.7 EUR.

What is Redcare Pharmacy NV's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Redcare Pharmacy NV's revenue is 38%. The projected CAGR for the next 4 years is 19%.

Back to Top